Genfit (GNFT) Misses in Late-stage NASH Trial, SanaCurrents Closes Position
Genfit S.a. (NASDAQ:GNFT) announced after the market closed on May [...]
-
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020 GalleryAcceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Onconova Coverage suspended, Oragenics falls short in Phase II trial. [...]
Genfit (GNFT) Probability Sentiment
Genfit S.a. (NASDAQ:GNFT) Probability Sentiment [...]